Legal News

Life Sciences weekly highlights—30 July 2020

Published on: 30 July 2020

Table of contents

  • Coronavirus (COVID-19)
  • Coronavirus (COVID-19): Pay no import duty and VAT on medical supplies, equipment and protective garments
  • Coronavirus (COVID-19)—MHRA on-site Good Practice inspections to resume
  • Amending Decision on relief from import duties and VAT exemption on importation granted for goods to combat coronavirus (COVID-19) published in Official Journal
  • Coronavirus (COVID-19)—Government invests over £100m to manufacture vaccines
  • Commons opens inquiry into role of technology in UK’s recovery from coronavirus (COVID-19)
  • Coronavirus (COVID-19)—UK’s decision to reject EU vaccine scheme challenged
  • Additional doses of coronavirus (COVID-19) vaccine secured by government
  • EMA reviews the use of dexamethasone to treat coronavirus (COVID-19)
  • Coronavirus (COVID-19)—Lloyd’s to insure transport of vaccine to emerging economies
  • More sections of this document available when you sign-in to Lexis+ or register for a free trial.

Article summary

This week's edition of Life Sciences weekly highlights includes the latest Brexit and coronavirus (COVID-19) developments, the publication of a working draft of the proposed 2021 Pharmaceutical Code of Practice currently under consultation and an updated draft of comprehensive Q&A guidance relating to Regulation (EU) 536/2014 (the Clinical Trials Regulation) and the launch by Innovation Medicines Initiative (IMI) of its blockchain project PharmaLedger.

Popular documents